Bjursten S - Search Results

1

Intussusceptive Angiogenesis in Human Metastatic Malignant Melanoma.

Pandita A, Ekstrand M, Bjursten S, Zhao Z, Fogelstrand P, Le Gal K, Ny L, Bergo MO, Karlsson J, Nilsson JA, Akyürek LM, Levin MC, Borén J, Ewald AJ, Mostov KE, Levin M. Pandita A, et al. Among authors: bjursten s. Am J Pathol. 2021 Nov;191(11):2023-2038. doi: 10.1016/j.ajpath.2021.07.009. Epub 2021 Aug 14. Am J Pathol. 2021. PMID: 34400131 Free PMC article.

2

Checkpoint inhibitor-induced sarcoid reaction mimicking bone metastases.

Jespersen H, Bjursten S, Ny L, Levin M. Jespersen H, et al. Among authors: bjursten s. Lancet Oncol. 2018 Jun;19(6):e327. doi: 10.1016/S1470-2045(18)30252-3. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29893264 No abstract available.

3

Real-world data on PD-1 inhibitor therapy in metastatic melanoma.

Arheden A, Skalenius J, Bjursten S, Stierner U, Ny L, Levin M, Jespersen H. Arheden A, et al. Among authors: bjursten s. Acta Oncol. 2019 Jul;58(7):962-966. doi: 10.1080/0284186X.2019.1620966. Epub 2019 May 31. Acta Oncol. 2019. PMID: 31151362

4

Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma.

Bjursten S, Vannas C, Filges S, Puls F, Pandita A, Fagman H, Ståhlberg A, Levin M. Bjursten S, et al. Case Rep Oncol. 2019 Nov 21;12(3):872-879. doi: 10.1159/000504291. eCollection 2019 Sep-Dec. Case Rep Oncol. 2019. PMID: 31824282 Free PMC article.

5

Dynamic ctDNA evaluation of a patient with BRAFV600E metastatic melanoma demonstrates the utility of ctDNA for disease monitoring and tumor clonality analysis.

Vannas C, Bjursten S, Filges S, Fagman H, Ståhlberg A, Levin M. Vannas C, et al. Among authors: bjursten s. Acta Oncol. 2020 Nov;59(11):1388-1392. doi: 10.1080/0284186X.2020.1802064. Epub 2020 Aug 8. Acta Oncol. 2020. PMID: 32772605 No abstract available.

6

Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.

Bjursten S, Pandita A, Zhao Z, Fröjd C, Ny L, Jensen C, Ullerstam T, Jespersen H, Borén J, Levin M, Zetterberg H, Rudin A, Levin M. Bjursten S, et al. J Immunother Cancer. 2021 Jul;9(7):e002732. doi: 10.1136/jitc-2021-002732. J Immunother Cancer. 2021. PMID: 34215689 Free PMC article.

7

Early Increase of Circulating Transitional B Cells and Autoantibodies to Joint-Related Proteins in Patients With Metastatic Melanoma Developing Checkpoint Inhibitor-Induced Inflammatory Arthritis.

Gatto M, Bjursten S, Jonsson CA, Agelii ML, Jonell C, McGrath S, Lönnblom E, Sareila O, Holmdahl R, Rudin A, Levin M, Gjertsson I. Gatto M, et al. Among authors: bjursten s. Arthritis Rheumatol. 2023 May;75(5):856-863. doi: 10.1002/art.42406. Epub 2023 Mar 14. Arthritis Rheumatol. 2023. PMID: 36409578

8

Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.

Brynjarsdottir HB, Bjursten S, Levin M, Gjertsson I, Rudin A. Brynjarsdottir HB, et al. Among authors: bjursten s. J Rheumatol. 2023 Sep;50(9):1195-1197. doi: 10.3899/jrheum.221182. Epub 2023 Apr 1. J Rheumatol. 2023. PMID: 37003605 No abstract available.

9

Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammation.

Bjursten S, Zhao Z, Al Remawi H, Studahl M, Pandita A, Simrén J, Zetterberg H, Lundell AC, Rudin A, Ny L, Levin M. Bjursten S, et al. EBioMedicine. 2024 Feb;100:104955. doi: 10.1016/j.ebiom.2023.104955. Epub 2024 Jan 3. EBioMedicine. 2024. PMID: 38171113 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page